Topics

11/13/19

Two Jacobs School of Medicine and Biomedical Sciences’ researchers studying how to develop novel, non-addicting painkillers have each been issued awards by the Helping to End Addiction Long-term (HEAL) Initiative, a prestigious and highly competitive program from the National Institutes of Health.

9/10/19

The Jacobs School of Medicine and Biomedical Sciences continues to be at the forefront in combating the opioid overdose crisis.

8/20/19

Jun-Xu Li, MD, PhD, has been awarded a five-year, $2 million National Institutes of Health grant to investigate a novel therapy that may prove more powerful than currently available smoking cessation treatments.

8/13/19

A program developed by emergency medicine physicians at the Jacobs School of Medicine and Biomedical Sciences to expedite patient access to comprehensive and effective opioid use disorder treatment is expanding statewide.

8/1/19

Gabriela K. Popescu, PhD, professor of biochemistry, will use funding from the National Institutes of Health (NIH) to study the gating mechanisms of fast neurotransmitter brain receptors.

7/22/19

The Jacobs School of Medicine and Biomedical Sciences and UB’s Clinical and Research Institute on Addictions (CRIA) played host to a prestigious Fulbright Enrichment Seminar on the opioid epidemic that brought 79 Fulbright Foreign Students from 51 countries to downtown Buffalo.

7/12/19

Shifts in illicit substance use among American youth will compel primary care physicians to monitor new products and how they are used, according to a study by Jacobs School of Medicine and Biomedical Sciences researchers published in American Family Physician.

6/21/19

Medical student Esha Chebolu has been selected to participate in a yearlong residential program that trains the next generation of clinician-scientists and biomedical researchers on the National Institutes of Health (NIH) campus in Bethesda, Maryland.

6/11/19

Andrew H. Talal, MD — who pioneered the use of telemedicine to treat patients with hepatitis C virus (HCV) in opioid treatment programs — has shared the successes of this approach with the National Academy of Medicine (NAM).

5/30/19

Two institutions within the University at Buffalo have joined the National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic.

3/7/19

Jun-Xu Li, MD, PhD, associate professor of pharmacology and toxicology, is being recognized by the American Society for Pharmacology and Experimental Therapeutics (ASPET) with the inaugural JH Woods Early Career Award in Behavioral Pharmacology.

2/7/19

Caroline E. Bass, PhD, assistant professor of pharmacology and toxicology, received a child care award to attend the Federation of European Neuroscience Societies (FENS) Forum in Berlin in July.

1/24/19

Researchers in the Department of Emergency Medicine are the first to clinically assess and validate a rule regarding the length of observation time necessary before opioid overdose patients can be safely discharged from an emergency department (ED).

1/14/19

University at Buffalo researchers have received a $2.7 million grant from the National Institutes of Health to continue their study of health outcomes among members of the military.

12/11/18

Kenneth E. Leonard, PhD, professor of psychiatry and director of the UB Clinical and Research Institute on Addictions (CRIA), and Peter L. Elkin, MD, professor and chair of biomedical informatics, have been awarded a two-year, $386,013 grant from the National Institute on Alcohol Abuse and Alcoholism to assess what risks may occur for people with alcohol use disorder (AUD) who use prescription painkillers.

12/11/18

Jennifer A. Martin, a doctoral student in the Department of Pharmacology and Toxicology, has received a prestigious Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience Award from the National Institutes of Health (NIH).

12/5/18

The National Institutes of Health is funding researchers in the Department of Pharmacology and Toxicology to study the effects of drinking, smoking and marijuana use during pregnancy.

12/3/18

An innovative, cost-effective program at more than a dozen hospitals in Western New York provides medication-assisted treatment to opioid use disorder patients in emergency departments (EDs) and rapidly transitions them into long-term treatment at a community clinic, all within about 48 hours.

11/20/18

Interprofessional collaboration is a key component in addressing the nation’s opioid epidemic, students from the Jacobs School of Medicine and Biomedical Sciences and other UB schools were told during the third annual forum on the topic.

9/13/18

A preclinical study conducted by researchers in the Department of Pharmacology and Toxicology has shown for the first time that a class of proteins are important in the neurobiology of relapse or drug-seeking behaviors.